ESC Professional Premium Access

Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Masami Nishino

Osaka Rosai Hospital, Sakai (Japan)
0 follower

6 more presentations in this session

Association between dapagliflozin, cardiac biomarkers, and cardiac remodeling in patients with diabetes mellitus and heart failure: a post-hoc analysis of a randomized study

Speaker: Doctor A. Xanthopoulos (Larissa, GR)

Thumbnail

Biomarker profiles of favorable ventricular remodeling in heart failure patients with reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial

Speaker: Doctor J. Tromp (Singapore, SG)

Thumbnail

Intravenous iron administration in patients with heart failure alters endothelial homeostasis with early release of endothelial microvesicles and subsequent mobilization of endothelial progenitor cell

Speaker: Doctor S. Mause (Aachen, DE)

Thumbnail

Effects of percutaneous coronary intervention on improvement of left ventricular ejection fraction among chronic coronary syndrome patients with left ventricular systolic dysfunction

Speaker: Doctor L. Qiao (Guangzhou, CN)

Thumbnail

Functional mitral regurgitation and ventricular arrhythmias in patients with cardiac resynchronization therapy

Speaker: Doctor A. Yoshimura (Tokyo, JP)

Thumbnail

Access the full session

Pathophysiology of heart failure: effects of interventions

Speakers: Doctor M. Nishino, Doctor A. Xanthopoulos, Doctor J. Tromp, Doctor S. Mause, Doctor L. Qiao...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb